Search results
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 16 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 hours agoLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript May 7, 2024...
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Zacks via Yahoo Finance· 9 hours agoThe upside was driven by increased royalties from Amgen’s Kyprolis, Jazz Pharmaceuticals’ Rylaze, ...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 6 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Merck First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 3 days agoNYSE:MRK Earnings and Revenue Growth May 6th 2024 Merck Revenues and Earnings Beat Expectations...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill via Yahoo Finance· 4 hours agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
A Look at Pharma ETFs Post Q1 Earnings
Zacks via Yahoo Finance· 1 day agoETF Angle iShares U.S. Pharmaceuticals ETF (IHE) iShares U.S. Pharmaceuticals ETF provides exposure to 34 U.S. companies that manufacture prescription or...
UK’s leading lab supplier launches investigation into N-word slurs on products
The Independent via Yahoo News· 16 hours ago(Screenshot) Cell culture lines, across a range of ethnicities, are widely used in scientific...
Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced...
Benzinga· 18 hours agoJim Cramer, the host of CNBC’s “Mad Money,” has warned investors about the current state of the...
Armata Pharmaceuticals Q1 2024 Earnings: Narrower Losses and Strategic Advances
GuruFocus.com via Yahoo Finance· 24 hours agoCompany Overview Armata Pharmaceuticals is at the forefront of developing pathogen-specific bacteriophage therapeutics for difficult-to-treat bacterial infections. The company ...
